Non-recurrent | Recurrent | p Value | |
Median (min–max) | Median (min–max) | ||
No. Age | 5 (45%) 41.00 (28.00–81.00) | 6 (55%) 51.00 (29–76) | 0.855* |
Duration (months) | 48.00 (1.00–60.00) | 59.50 (12–204) | 0.313* |
Visual acuity | 1.20 (0–1.40) | 0.20 (0–1.30) | 0.195* |
Cell | 0.50 (0.50–4.00) | 0.25 (0–1.00) | 0.159* |
KPs | 0.182† | ||
No | 1 (20.00) | – | |
Yes | 4 (80.00) | 6 (100.00) | |
IOP | 32.00 (15–44) | 22.5 (14–40) | 0.314* |
Antiglaucoma drug | 4 (1–6) | 3 (0–4) | 0.511* |
Steroid | 4 (2–16) | 4 (4–6) | 0.672* |
*Mann-Whitney U test.
†Fisher's exact test.
Significant (p<0.05).
In case 8, recurrent CMV uveitis was defined as unilateral, high IOP, coin-shaped KPs, localised corneal oedema and normal retina while recurrent in Behcet’s disease should be bilateral, low IOP, fine KPs or some retinitis progression.
CMV, cytomegalovirus; IOP, intraocular pressure; KPs, keratic precipitates.